This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: University of Florida Research Foundation Inc., University of Pennsylvania. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Philadelphia, PA (US) (2017 - 2019)
- Lafayette Hill, PA (US) (2021)
Company Filing History:
3 out of 3,052 
3 out of 2,659 
Years Active: 2017-2021
Title: Artur V Cideciyan: Innovator in Gene Therapy for Retinal Diseases
Introduction
Artur V Cideciyan is a prominent inventor based in Philadelphia, PA, known for his significant contributions to the field of gene therapy, particularly in the treatment of retinal diseases. With a total of 3 patents, Cideciyan has made remarkable strides in developing innovative methods to address conditions such as retinitis pigmentosa.
Latest Patents
Cideciyan's latest patents include groundbreaking work on AAV vectors for the treatment of dominant retinitis pigmentosa. This patent focuses on methods and compositions for treating retinitis pigmentosa by delivering an interfering nucleic acid to reduce the expression of mutant rho alleles associated with the disease. Additionally, he has developed AAV-mediated gene therapy for RPGR X-linked retinal degeneration, which aims to prevent or ameliorate vision loss associated with retinitis pigmentosa and X-linked retinitis pigmentosa through the administration of a recombinant adeno-associated virus carrying a normal RPGR gene.
Career Highlights
Throughout his career, Cideciyan has been affiliated with esteemed institutions such as the University of Pennsylvania and the University of Florida Research Foundation. His work has significantly advanced the understanding and treatment of genetic retinal disorders, showcasing his dedication to improving patient outcomes.
Collaborations
Cideciyan has collaborated with notable colleagues, including William Beltran and Gustavo D Aguirre, further enhancing the impact of his research in the field of gene therapy.
Conclusion
Artur V Cideciyan's innovative work in gene therapy represents a vital contribution to the treatment of retinal diseases. His patents and collaborations reflect a commitment to advancing medical science and improving the lives of those affected by genetic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile